Clinical Trials

455 enrolled 13 charts

Colorectal Adenocarcinoma

NCT04215731 2026-03-03

FOBEAR

582 enrolled

Rectal Neoplasms

NCT06888817 2026-02-25

BRAINS

408 enrolled

Brain Neoplasms, Glioma, Radiation Injuries

NCT05171660 2026-02-17

Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer

446 enrolled

Colorectal Neoplasms

NCT04649489 2026-01-15

TALENTOP

501 enrolled

Venous Thrombosis

NCT06580314 2026-01-14

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

880 enrolled

Ovarian Neoplasms

NCT06791512 2025-12-24

BASKETⅢ

166 enrolled

Phase 3 Not yet recruiting

Colorectal Neoplasms

NCT07271355 2025-12-09

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

129 enrolled

Appendiceal Neoplasms, Colorectal Neoplasms

NCT06733038 2025-12-08

AtezoTRIBE2

238 enrolled

Colorectal Neoplasms

NCT07235930 2025-11-19

Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer

292 enrolled

Non-Resectable Pancreas Carcinoma

NCT05009082 2025-09-10

Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer

970 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01951482 2025-08-17

Pemetrexed/Platinum With or Without Bevacizumab in Brain Metastases From Patients With EGFR/ALK Negative Non-Squamous Non-small Cell Lung Cancer

160 enrolled

Brain Neoplasms

NCT06471465 2025-08-17

BRADI

84 enrolled

Brain Neoplasms

NCT03828227 2025-07-18

COLAGE

49 enrolled

Colorectal Neoplasms

NCT02885753 2025-07-09

OSCAR

348 enrolled

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT05482516 2025-05-22

MRD-GI

20 enrolled

Colonic Neoplasms, Carcinoma, Hepatocellular, Rectal Neoplasms

NCT02934529 2025-04-16

AIO-KRK-0114

673 enrolled

Colorectal Neoplasms

NCT02891824 2025-02-11

ATALANTE

614 enrolled

Ovarian Neoplasms

NCT04732598 2025-02-05

AMBITION

280 enrolled

Breast

Breast Neoplasms

NCT04803994 2025-01-07

The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma

434 enrolled

Carcinoma, Hepatocellular

NCT01167725 2024-12-27

Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer

Phase 3 Terminated

340 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT03635021 2024-10-21

CR-SEQUENCE

419 enrolled

Phase 3 Not yet recruiting

Colorectal Neoplasms

NCT06642844 2024-10-15

PHARBEVACOL

244 enrolled

Unresectable Metastatic Colorectal Cancer

NCT05271240 2024-09-19

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

432 enrolled

Brain Neoplasms, Glioblastoma, Glioma

NCT06566755 2024-08-22

Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal Cancer

30 enrolled

Colorectal Neoplasms

NCT05055908 2024-08-02

BECOME

12,000 enrolled

Lung Neoplasms

NCT01910610 2024-03-12

STRATEGIC-1

464 enrolled

Colorectal Cancer Metastatic

NCT01303679 2023-09-06

1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

Phase 3 Terminated

117 enrolled

Breast

First Line Metastatic Breast Cancer

NCT03950154 2023-08-01

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

198 enrolled

Colorectal Neoplasms

NCT05718466 2023-07-17

Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy

35 enrolled 13 charts

Glioblastoma, Recurrence

NCT04201561 2023-06-26

SELENIUM

68 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases

NCT05797467 2023-05-24

Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients

366 enrolled

Colorectal Neoplasms

NCT01718873 2023-04-12

OBELICS

230 enrolled 12 charts

Neoplasm Metastasis, Colorectal Neoplasms

NCT03991403 2023-04-03

Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC

228 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05104281 2023-03-29

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

60 enrolled

Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01802749 2023-03-24

MITO16MANGO2b

406 enrolled

Ovarian Neoplasms

NCT02633189 2023-03-24

BEVERLY

200 enrolled

Non-squamous Non-small Cell Lung Cancer

NCT01763671 2023-03-14

Ultimate

166 enrolled

Lung Neoplasms

NCT02761070 2023-03-08

RE-GEND

146 enrolled

Glioblastoma, Recurrence, Disease Progression

NCT05648071 2022-12-13

SPBPDC

60 enrolled

Advanced Non-squamous Non-Small-Cell Lung Cancer

NCT01462890 2022-07-20

BOOST

927 enrolled

Fallopian Tube Neoplasms, Genital Diseases, Female, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Neoplasms

NCT02743923 2021-12-21

Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer

203 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04188145 2021-10-28

BEVAMAINT

400 enrolled

Colorectal Neoplasms

NCT04781270 2021-09-27

mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases

308 enrolled

Colorectal Neoplasms

NCT04679064 2021-08-27

NItCHE-MITO33

427 enrolled

Ovarian Neoplasms

NCT03806049 2021-07-15

Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer

Phase 3 Withdrawn

Ovarian Neoplasms

NCT04525326 2020-08-25

Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases

584 enrolled

Colorectal Neoplasms

NCT00265850 2020-05-07

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

2,334 enrolled 9 charts

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00544700 2020-02-20

Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer

Phase 3 Terminated

265 enrolled